360 related articles for article (PubMed ID: 25400789)
1. Mesonephric adenocarcinoma of the uterine corpus.
Wu H; Zhang L; Cao W; Hu Y; Liu Y
Int J Clin Exp Pathol; 2014; 7(10):7012-9. PubMed ID: 25400789
[TBL] [Abstract][Full Text] [Related]
2. Mesonephric Adenocarcinoma of the Uterine Corpus: A Case Report and Diagnostic Pitfall.
Kim SS; Nam JH; Kim GE; Choi YD; Choi C; Park CS
Int J Surg Pathol; 2016 Apr; 24(2):153-8. PubMed ID: 26510860
[TBL] [Abstract][Full Text] [Related]
3. Mesonephric adenocarcinoma in the uterine corpus: A case report and review of the literature.
Tang X; Li L; He Y
Indian J Pathol Microbiol; 2021; 64(4):806-809. PubMed ID: 34673610
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L
Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742
[TBL] [Abstract][Full Text] [Related]
5. Mesonephric adenocarcinoma of the uterine corpus: a case report and review of the literature.
Wani Y; Notohara K; Tsukayama C
Int J Gynecol Pathol; 2008 Jul; 27(3):346-52. PubMed ID: 18580312
[TBL] [Abstract][Full Text] [Related]
6. Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation.
Ordi J; Nogales FF; Palacin A; Márquez M; Pahisa J; Vanrell JA; Cardesa A
Am J Surg Pathol; 2001 Dec; 25(12):1540-5. PubMed ID: 11717545
[TBL] [Abstract][Full Text] [Related]
7. Mesonephric adenocarcinoma of the uterine corpus with intracystic growth completely confined to the myometrium: a case report and literature review.
Ando H; Watanabe Y; Ogawa M; Tamura H; Deguchi T; Ikeda K; Fujitani M; Shioji M; Tsujie T; Doi R; Wakimoto A; Adachi S
Diagn Pathol; 2017 Aug; 12(1):63. PubMed ID: 28841919
[TBL] [Abstract][Full Text] [Related]
8. Mesonephric Adenocarcinoma of the Uterine Corpus: A Report on 2 Cases With Comparison to Its Cervical Counterpart.
Liang Y; Shi H; Zhu X; Yu M; Zhang X
Int J Gynecol Pathol; 2020 Nov; 39(6):546-551. PubMed ID: 31985582
[TBL] [Abstract][Full Text] [Related]
9. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β.
Kenny SL; McBride HA; Jamison J; McCluggage WG
Am J Surg Pathol; 2012 Jun; 36(6):799-807. PubMed ID: 22456609
[TBL] [Abstract][Full Text] [Related]
10. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
Mirkovic J; McFarland M; Garcia E; Sholl LM; Lindeman N; MacConaill L; Dong F; Hirsch M; Nucci MR; Quick CM; Crum CP; McCluggage WG; Howitt BE
Am J Surg Pathol; 2018 Feb; 42(2):227-233. PubMed ID: 28984674
[TBL] [Abstract][Full Text] [Related]
11. Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: a case report and review of the literature.
Meguro S; Yasuda M; Shimizu M; Kurosaki A; Fujiwara K
Diagn Pathol; 2013 May; 8():74. PubMed ID: 23651629
[TBL] [Abstract][Full Text] [Related]
12. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract.
Howitt BE; Emori MM; Drapkin R; Gaspar C; Barletta JA; Nucci MR; McCluggage WG; Oliva E; Hirsch MS
Am J Surg Pathol; 2015 Oct; 39(10):1411-9. PubMed ID: 26135559
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.
Yano M; Shintani D; Katoh T; Hamada M; Ito K; Kozawa E; Hasegawa K; Yasuda M
Diagn Pathol; 2019 Jun; 14(1):54. PubMed ID: 31174566
[TBL] [Abstract][Full Text] [Related]
14. Incidental mesonephric remnant hyperplasia of the jejunal mesentery: A diagnostic challenge.
Val-Bernal JF; Mayorga MM; Calapaquí-Terán AK; Toledo E
Pathol Res Pract; 2021 Apr; 220():153388. PubMed ID: 33647867
[TBL] [Abstract][Full Text] [Related]
15. Mesonephric Adenocarcinoma of the Uterine Corpus: Report of 2 Cases and Review of the Literature.
Zhang L; Cai Z; Ambelil M; Conyers J; Zhu H
Int J Gynecol Pathol; 2019 May; 38(3):224-229. PubMed ID: 29543603
[TBL] [Abstract][Full Text] [Related]
16. Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis.
Dundr P; Gregová M; Němejcová K; Bártů M; Hájková N; Hojný J; Stružinská I; Fischerová D
Diagn Pathol; 2020 Jul; 15(1):91. PubMed ID: 32693840
[TBL] [Abstract][Full Text] [Related]
17. Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix.
Goyal A; Yang B
Int J Gynecol Pathol; 2014 Nov; 33(6):613-9. PubMed ID: 25272301
[TBL] [Abstract][Full Text] [Related]
18. Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma.
McCluggage WG; Vosmikova H; Laco J
Int J Gynecol Pathol; 2020 Jan; 39(1):84-92. PubMed ID: 30575604
[TBL] [Abstract][Full Text] [Related]
19. Mesonephric proliferations of the female genital tract.
Howitt BE; Nucci MR
Pathology; 2018 Feb; 50(2):141-150. PubMed ID: 29269124
[TBL] [Abstract][Full Text] [Related]
20. Wolffian adnexal tumor, so-called female adnexal tumor of probable Wolffian origin (FATWO): immunohistochemical evidence in support of a Wolffian origin.
Devouassoux-Shisheboran M; Silver SA; Tavassoli FA
Hum Pathol; 1999 Jul; 30(7):856-63. PubMed ID: 10414506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
